CureVac (CVAC)

CureVac (CVAC) Stock Price & Analysis


CVAC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.63 - $15.62
Previous Close$9.71
Average Volume (3M)502.50K
Market Cap
Enterprise Value$1.72B
Total Cash (Recent Filing)€495.80M
Total Debt (Recent Filing)€42.09M
Price to Earnings (P/E)-7.2
Aug 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding194,950,000
10 Day Avg. Volume443,155
30 Day Avg. Volume502,496
Standard Deviation0.32
Financial Highlights & Ratios
Price to Book (P/B)4.05
Price to Sales (P/S)28.08
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside83.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was CureVac’s price range in the past 12 months?
CureVac lowest stock price was $5.63 and its highest was $15.62 in the past 12 months.
    What is CureVac’s market cap?
    Currently, no data Available
    When is CureVac’s upcoming earnings report date?
    CureVac’s upcoming earnings report date is Aug 16, 2023 which is in 67 days.
      How were CureVac’s earnings last quarter?
      Currently, no data Available
      Is CureVac overvalued?
      According to Wall Street analysts CureVac’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does CureVac pay dividends?
        CureVac does not currently pay dividends.
        What is CureVac’s EPS estimate?
        CureVac’s EPS estimate is -$0.31.
          How many shares outstanding does CureVac have?
          CureVac has 223,841,550 shares outstanding.
            What happened to CureVac’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of CureVac?
            Among the largest hedge funds holding CureVac’s share is RA Capital Management. It holds CureVac’s shares valued at 85M.


              CureVac Stock Smart Score

              The CureVac stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description


              CureVac BV a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. The company's product portfolio includes clinical and preclinical candidates across multiple disease indications in oncology, prophylactic vaccines and protein therapy. Its clinical programs are CV8102, which it is evaluating in a Phase 1 clinical trial for the treatment of four types of solid tumors, and CV7202, which it is investigating in a Phase 1 clinical trial for potential vaccination against rabies. It is also rapidly advancing its mRNA vaccine program against coronavirus SARS- CoV-2), for which the company initiated a Phase 1 clinical trial.


              Top 5 ETFs holding CVAC

              Market Value
              Smart Score
              iShares NASDAQ US Biotechnology UCITS ETF
              Fidelity Nasdaq Composite Index ETF
              Vanguard ESG U.S. Stock ETF
              Invesco Nasdaq Biotechnology ETF
              Vanguard ESG North America All Cap UCITS ETF USD
              Up to five ETFs with an Outperform Smart Score that hold CVAC. The ETFs are listed according to market value of CVAC within the ETF


              Forecast EPS vs Actual EPS

              Currently, no data available
              Please return soon. This page is being updated.

              Similar Stocks
              Price & Change
              BioNTech SE

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis